-
Lerdelimumab (CAT-152,
intended trade name Trabio) is a
human monoclonal antibody and an
immunosuppressive drug
targeting TGF beta 2. It was
being developed...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
-
chronic myelomonocytic leukemia and
juvenile myelomonocytic leukemia Lerdelimumab mab
human TGF-β2
reduction of
scarring after glaucoma surgery Leronlimab...
-
lepirudin (INN)
leptacline (INN)
Leqembi Leqselvi lercanidipine (INN)
lerdelimumab (INN)
lergotrile (INN)
leridistim (INN)
lerisetron (INN)
leritine lersivirine...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
- GDF (10 (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761...
